Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations

NCT00070785 ·Status: COMPLETED

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

NCT04554914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of the Safety and Efficacy of EBV Specific T-cell Lines

NCT02580539 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

NCT05164094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)

NCT00058591 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

NCT07330440 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Sintilimab and Lenalidomide as a Treatment for CAEBV

NCT04518982 ·Status: UNKNOWN ·Phase: PHASE2

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

NCT02822495 ·Status: NO_LONGER_AVAILABLE

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

NCT04449276 ·Status: COMPLETED ·Phase: PHASE1

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

NCT03789617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)

NCT00078546 ·Status: COMPLETED ·Phase: PHASE1

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

NCT05831111 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies

NCT00002663 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of HBV-001 D1 in Healthy Adults

NCT00936429 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection

NCT04308278 ·Status: RECRUITING ·Phase: PHASE4

An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease

NCT02271347 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198

NCT04787211 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

NCT04785144 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

NCT06655324 ·Status: RECRUITING ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

NCT04479631 ·Status: COMPLETED ·Phase: PHASE1

Selinexol Combined With Dexamethasone in the Treatment of CAEBV

NCT05347381 ·Status: UNKNOWN ·Phase: PHASE3

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

NCT02776761 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

NCT05992935 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

NCT04752644 ·Status: COMPLETED ·Phase: PHASE2

Etoposide in the First-line Treatment of Adult EBV-HLH

NCT03742115 ·Status: UNKNOWN ·Phase: PHASE3